The "GEnomics of Musculo Skeletal Traits TranslatiOnal NEtwork": Origins, Rationale, Organization, and Prospects.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 14 05 2021
accepted: 15 07 2021
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 11 2 2022
Statut: epublish

Résumé

Musculoskeletal research has been enriched in the past ten years with a great wealth of new discoveries arising from genome wide association studies (GWAS). In addition to the novel factors identified by GWAS, the advent of whole-genome and whole-exome sequencing efforts in family based studies has also identified new genes and pathways. However, the function and the mechanisms by which such genes influence clinical traits remain largely unknown. There is imperative need to bring multidisciplinary expertise together that will allow translating these genomic discoveries into useful clinical applications with the potential of improving patient care. Therefore "GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork" (GEMSTONE) aims to set the ground for the: 1) functional characterization of discovered genes and pathways; 2) understanding of the correspondence between molecular and clinical assessments; and 3) implementation of novel methodological approaches. This research network is funded by

Identifiants

pubmed: 34484122
doi: 10.3389/fendo.2021.709815
pmc: PMC8415473
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

709815

Informations de copyright

Copyright © 2021 Koromani, Alonso, Alves, Brandi, Foessl, Formosa, Morgenstern, Karasik, Kolev, Makitie, Ntzani, Pietsch, Ohlsson, Rauner, Soe, Soldatovic, Teti, Valjevac and Rivadeneira.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hum Mol Genet. 2017 Oct 1;26(R2):R193-R201
pubmed: 28977450
Front Endocrinol (Lausanne). 2022 Dec 23;13:1110170
pubmed: 36619575
J Bone Miner Res. 2020 Sep;35(9):1623-1625
pubmed: 32845524
J Clin Endocrinol Metab. 2000 Nov;85(11):4118-24
pubmed: 11095442
N Engl J Med. 1999 Sep 16;341(12):879-84
pubmed: 10486419
Front Endocrinol (Lausanne). 2021 Nov 30;12:731217
pubmed: 34938269
J Bone Miner Res. 2020 Sep;35(9):1626-1633
pubmed: 32777102
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Cell. 2001 Nov 16;107(4):513-23
pubmed: 11719191
N Engl J Med. 2013 Oct 17;369(16):1529-36
pubmed: 24088043
Nature. 1997 Jun 26;387(6636):903-8
pubmed: 9202122
Am J Hum Genet. 2001 Mar;68(3):577-89
pubmed: 11179006
Nature. 1996 Dec 5;384(6608):455-8
pubmed: 8945470
Front Endocrinol (Lausanne). 2021 Aug 13;12:709711
pubmed: 34539568
Nature. 2013 May 23;497(7450):517-20
pubmed: 23644456
J Bone Miner Res. 2018 Aug;33(8):1407-1416
pubmed: 29750828
Nat Rev Rheumatol. 2016 Jun;12(6):323-34
pubmed: 27052486
Trends Endocrinol Metab. 2016 May;27(5):262-281
pubmed: 27079517
Nature. 2021 Feb;590(7845):212-215
pubmed: 33568828
N Engl J Med. 2013 May 9;368(19):1809-16
pubmed: 23656646
Nature. 2012 Sep 6;489(7414):46-8
pubmed: 22962707
N Engl J Med. 2002 May 16;346(20):1513-21
pubmed: 12015390
Nat Commun. 2016 Jan 06;7:10129
pubmed: 26733130
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R67-74
pubmed: 16651371
Nat Rev Drug Discov. 2015 Apr;14(4):223-5
pubmed: 25829267
N Engl J Med. 2006 Aug 3;355(5):467-77
pubmed: 16885550
Nat Genet. 2015 Aug;47(8):856-60
pubmed: 26121088
Lancet. 2011 Apr 9;377(9773):1276-87
pubmed: 21450337
Nat Rev Genet. 2010 Jun;11(6):415-25
pubmed: 20479773
Clin Geriatr Med. 2017 Feb;33(1):17-26
pubmed: 27886695
Nucleic Acids Res. 2014 Jan;42(Database issue):D1001-6
pubmed: 24316577
J Bone Miner Res. 2011 Oct;26(10):2411-8
pubmed: 21710615
Front Endocrinol (Lausanne). 2020 Oct 09;11:556610
pubmed: 33162933

Auteurs

Fjorda Koromani (F)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.

Nerea Alonso (N)

Rheumatology and Bone Disease Unit, CGEM-IGMM, University of Edinburgh, Edinburgh, United Kingdom.

Ines Alves (I)

ANDO Portugal, Évora, Portugal.

Maria Luisa Brandi (ML)

Department of Surgery and Translational Medicine (M.L.B.), University of Florence, Florence, Italy.

Ines Foessl (I)

Department of Internal Medicine, Division of Endocrinology and Diabetology, Endocrinology Lab Platform, Medical University Graz, Graz, Austria.

Melissa M Formosa (MM)

Department of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta.

Milana Frenkel Morgenstern (MF)

Azrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan, Israel.

David Karasik (D)

Azrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan, Israel.

Mikhail Kolev (M)

Department of Mathematics, South-West University Neofit Rilski, Blagoevgrad, Bulgaria.

Outi Makitie (O)

Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.

Evangelia Ntzani (E)

Department of Hygiene and Epidemiology, Medical School, University of Ioannina, Ioannina, Greece.
Department of Health Services, Policy and Practice, Center for Research Synthesis in Health, School of Public Health, Brown University, Providence, RI, United States.

Barbara Obermayer Pietsch (BO)

Department of Internal Medicine, Division of Endocrinology and Diabetology, Endocrinology Lab Platform, Medical University Graz, Graz, Austria.

Claes Ohlsson (C)

Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Martina Rauner (M)

Department of Medicine III, Medical Faculty, Technische Universität Dresden, Dresden, Germany.

Kent Soe (K)

Clinical Cell Biology, Department of Pathology, Odense University Hospital, Odense, Denmark.
Clinical Cell Biology, Pathology Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Ivan Soldatovic (I)

Institute of Biostatistics, University of Belgrade, Belgrade, Serbia.

Anna Teti (A)

Department of Biotechnological and Applied Clinical Sciences, L'Aquila, Italy.

Amina Valjevac (A)

Department of Physiology, Medical Faculty University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Fernando Rivadeneira (F)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH